MedTrace Logo

A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women

NCT05066477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of salmon bone meal in preventing bone loss among perimenopausal women with reduced bone mass density.

Conditions

  • Osteopenia
  • Osteopenia of the Elderly

Interventions

DIETARY_SUPPLEMENT

CalGo

CalGo is a natural marine collagenic bone powder from salmon. The bone powder is a 100 % microcrystalline hydroxyapatite form of calcium and phosphorus. Furthermore it contains collagen type 2 and is enriched with vitamin D3.

OTHER

Placebo

Pure maltodextrin

Sponsors & Collaborators

  • Møre og Romsdal Hospital Trust

    collaborator OTHER

  • Hofseth Biocare ASA

    lead INDUSTRY

Principal Investigators

  • Øystein B Lian, MD, PhD · Møre og Romsdal Hospital Trust (Helse Møre og Romsdal), Kristiansund Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-22
Primary Completion
2025-06-12
Completion
2025-06-12

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05066477 on ClinicalTrials.gov